Global Pruritus Drugs Market 2022-2026

Global Pruritus Drugs Market 2022-2026

Technavio has been monitoring the pruritus drugs market and it is poised to grow by $ 6.87 bn during 2022-2026, progressing at a CAGR of 8.06% during the forecast period. Our report on the pruritus drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing preference for immunotherapy, rising prevalence of chronic diseases, and increasing awareness and rising use of therapeutics. In addition, the growing preference for immunotherapy is anticipated to boost the growth of the market as well.

The pruritus drugs market analysis includes the application segment and geographic landscape.

Technavio's pruritus drugs market is segmented as below:

By Application

• Hematologic pruritus
• Oncological pruritus
• Renal pruritus
• Endocrine pruritus
• Cholestatic pruritus

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW

This study identifies the emergence of novel treatment options as one of the prime reasons driving the pruritus drugs market growth during the next few years. Also, nanoparticle-enabled transdermal drug delivery systems and increasing research funding will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on pruritus drugs market covers the following areas:

• Pruritus drugs market sizing
• Pruritus drugs market forecast
• Pruritus drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pruritus drugs market vendors that include AbbVie Inc., Almirall SA, Astellas Pharma Inc., Bristol-Myers Squibb Co., Cara Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Cipla Ltd., GlaxoSmithKline Plc, and Lupin Ltd. Also, the pruritus drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.